Janus Henderson Group Plc - Oct 31, 2025 SCHEDULE 13G Report for ENANTA PHARMACEUTICALS INC Common Stock (ENTA)

Filing Manager
JANUS HENDERSON GROUP PLC
Reporting Manager
JANUS HENDERSON GROUP PLC
Security
ENANTA PHARMACEUTICALS INC Common Stock
Symbol
ENTA
Shares outstanding
28.9M shares
Disclosed Ownership
3.49M shares
Ownership
12.1%
Form type
SCHEDULE 13G
Date filed
11/7/2025, 12:10 PM
Date of event
Oct 31, 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
JANUS HENDERSON GROUP PLC 12.1% 3.49M 0 3.49M Kristin Mariani Head of North America Compliance, CCO
Janus Henderson Biotech Innovation Master Fund Ltd 10.6% 2.96M 0 2.96M Kristin Mariani Head of North America Compliance, CCO